These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9017250)

  • 1. Involvement of N-methyl-D-aspartate receptor in the delayed transneuronal regression of substantia nigra neurons in rats.
    Yamada K; Goto S; Yoshikawa M; Okamura A; Ushio Y
    Brain Res; 1996 Dec; 743(1-2):233-9. PubMed ID: 9017250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
    DeGiorgio LA; DeGiorgio N; Volpe BT
    Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous intraventricular drug infusion for the in vivo study of transneuronal degeneration in the striatonigral system of the rat.
    Yamada K; Goto S; Yoshikawa M; Okamura A; Ushio Y
    Brain Res Brain Res Protoc; 1997 Oct; 1(4):371-7. PubMed ID: 9384818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of heat shock response in deafferented neurons in the substantia nigra of rats.
    Yamada K; Goto S; Ushio Y
    Neuroscience; 1994 Oct; 62(3):793-801. PubMed ID: 7870307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat.
    Sarraf-Yazdi S; Sheng H; Miura Y; McFarlane C; Dexter F; Pearlstein R; Warner DS
    Anesth Analg; 1998 Jul; 87(1):72-8. PubMed ID: 9661549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the substantia nigra pars reticulata in sensorimotor gating, measured by prepulse inhibition of startle in rats.
    Koch M; Fendt M; Kretschmer BD
    Behav Brain Res; 2000 Dec; 117(1-2):153-62. PubMed ID: 11099769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deafferentiation-induced c-fos gene expression in subthalamic nucleus and substantia nigra reticulata is reduced by non-NMDA receptor antagonist.
    Saji M; Kimura M; Ishida G; Ohno K
    Brain Res; 1995 Dec; 703(1-2):165-74. PubMed ID: 8719629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin protects GABAergic and dopaminergic neurons in the nigrostriatal system in an experimental rat model of transient focal cerebral ischemia.
    Sabogal AM; Arango CA; Cardona GP; Céspedes ÁE
    Biomedica; 2014; 34(2):207-17. PubMed ID: 24967926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution, and morphology of cell death.
    Stefanis L; Burke RE
    Neuroscience; 1996 Oct; 74(4):997-1008. PubMed ID: 8895868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions.
    Volpe BT; Wildmann J; Altar CA
    Neuroscience; 1998 Apr; 83(3):741-8. PubMed ID: 9483558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease.
    Armentero MT; Fancellu R; Nappi G; Bramanti P; Blandini F
    Neurobiol Dis; 2006 Apr; 22(1):1-9. PubMed ID: 16289868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
    Kaur S; Ozer H; Starr M
    Eur J Pharmacol; 1997 Aug; 332(2):153-60. PubMed ID: 9286616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA; Graham DI; McCulloch J; Macrae IM
    Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transsynaptic cell death of neurons following striatopallidal lesions does not occur in substantia nigra pars reticulata in developing rats.
    Yoshimura M; Saji M
    Brain Res Dev Brain Res; 1998 Jan; 105(1):25-33. PubMed ID: 9497076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H; Ekinci AC; Starr MS
    Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic dizocilpine maleate (MK-801) treatment suppresses the effects of nigrostriatal dopamine deafferentation on enkephalin but not on substance P expression in the rat striatum.
    Hajji MD; Salin P; Kerkerian-Le Goff L
    Eur J Neurosci; 1996 May; 8(5):917-26. PubMed ID: 8743739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of transneuronal degeneration of neurons in the substantia nigra reticulata by ablation of the subthalamic nucleus.
    Saji M; Blau AD; Volpe BT
    Exp Neurol; 1996 Sep; 141(1):120-9. PubMed ID: 8797674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.